Adverum Biotechnologies
ADVM
ADVM
98 hedge funds and large institutions have $119M invested in Adverum Biotechnologies in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 39 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $155M → $119M (-$35.9M)
33% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 39
46% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 26
Holders
98
Holding in Top 10
2
Calls
$5.58M
Puts
$1.12M
Top Buyers
| 1 | +$1.84M | |
| 2 | +$1.71M | |
| 3 | +$1.55M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$919K |
| 5 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$449K |
Top Sellers
| 1 | -$2.17M | |
| 2 | -$1.81M | |
| 3 | -$1.78M | |
| 4 |
Morgan Stanley
New York
|
-$1.7M |
| 5 |
Millennium Management
New York
|
-$1.33M |